Ever Source Wealth Advisors, LLC Cure Vac N.V. Transaction History
Ever Source Wealth Advisors, LLC
- $1.95 Billion
- Q2 2025
A detailed history of Ever Source Wealth Advisors, LLC transactions in Cure Vac N.V. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 1,095 shares of CVAC stock, worth $5,869. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,095
Previous 666
64.41%
Holding current value
$5,869
Previous $1,000
400.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding CVAC
# of Institutions
102Shares Held
14.2MCall Options Held
270KPut Options Held
114K-
Black Rock Inc. New York, NY2.25MShares$12.1 Million0.0% of portfolio
-
Alpine Associates Management Inc. Englewood Cliffs, NJ1.97MShares$10.6 Million0.58% of portfolio
-
Bill & Melinda Gates Foundation Seattle, WA1.57MShares$8.41 Million10.6% of portfolio
-
Qube Research & Technologies LTD London, X01.18MShares$6.34 Million0.01% of portfolio
-
Water Island Capital LLC New York, NY957KShares$5.13 Million1.03% of portfolio
About CureVac N.V.
- Ticker CVAC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,467,008
- Market Cap $1B
- Description
- CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...